03.07.25 -- 9 Reasons Why You Should Consider AI In Analytical Instrument Qualification

Route scouting professionals – self-effacing hunters of small-molecule simplicity, searching for efficient pathways to commercial success, fearless in pointing out risks, and at times, dead ends. Today they face mounting challenges. Can artificial intelligence (AI) bring more clairvoyance to these battered scientists? “Absolutely,” says Dr. Jürgen Swienty-Busch of Elsevier.

Three combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

This presentation discusses outsourcing options for highly potent oral solid dose therapies and explains how CDMOs can transfer, handle, and deliver their product to clinics and to market.

Environmental considerations in pharmaceutical manufacturing strategies have become increasingly important in the face of additional calls to address pollution and sustainability practices globally.

Find out how reality capture was used to create a digital twin 750,000-square-foot Pfizer campus to support asset reinduction to Maximo EAM, saving Pfizer 3,000 hours per year.

Explore this interactive PDF with information about technologies and end-to-end integrated CDMO services, encompassing taste masking, controlled release, solubility enhancement, and dosing solutions.

Consider our global network’s cutting-edge medicinal chemistry capabilities and streamline your outsourcing needs with cost-effective solutions.

Partner with Curia’s global team of experts to streamline process development, scale-up, and cGMP manufacturing for your small molecule projects.